Both in Biotechnology
Adaptive Biotechnologies vs Denali Therapeutics
Over the past year ADPT returned +53.5% and DNLI returned +16.3%; their daily moves had a correlation of 0.29.
ADPT +53.5% DNLI +16.3%Growth of $1, one year, split-adjusted
| Metric | ADPT | DNLI |
|---|---|---|
| Price | $26.64 | $18.94 |
| Market cap | $4.25B | $3.03B |
| Today | −5.43% | −1.97% |
| 1 month | −2.7% | −7.7% |
| 6 months | +86.7% | +3.5% |
| Year to date | +64.0% | +14.7% |
| 1 year | +58.6% | +16.6% |
| Revenue growth (YoY) | +21.5% | — |
| Gross margin | 71.8% | 97.4% |
| Net margin | −55.6% | −3539.2% |
| P/E (TTM) | — | — |
| Price / sales | 13.8× | 840.0× |
| Net cash | $9.4M | $705.0M |
| Dividend yield | — | — |
| Volatility (60d) | 50.5% | 37.4% |
| Short % of float | 10.0% | 11.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).